Zimbabwe has rejected a major American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's demand for sensitive data.
This rejection came to light following a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "unbalanced".
A government spokesperson has since explained that the US was demanding access to biological samples for scientific study and profit while refused to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more dialogue to reach a deal agreeable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the security of citizens' medical information.
After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
As per reports, 16 African countries have so far signed these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.
"Effectively, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people should a future disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures previously set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This system is intended to ensure that when a country provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We encourage ongoing discussions with our US partners on how subsequent collaboration could be arranged in a way that honours the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that talks must proceed given that much of the nation's Aids initiatives relied on foreign aid.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it said.
The halted deal emphasises the ongoing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.